BioCentury | Jan 27, 2021
Deals

Jan. 26 Quick Takes: Sanofi to manufacture more than 100M doses of Comirnaty; plus Qiming, Nirogy, Takeda-Evozyne and Vir

...RMB 2.9 billion ($441.1 million) to invest in healthcare and technology companies, bringing the firm’s total...
BioCentury | Jan 26, 2021
Politics, Policy & Law

EU transparency scheme raises concerns over potential COVID-19 vaccine export restrictions

...procurement deal is for up to 400 million doses, or about 15% of the EU’s total...
BioCentury | Jan 22, 2021
Product Development

Lilly, AbCellera mAb could enable broad deployment for COVID without taxing infusion centers

...primary endpoint, the incidence of symptomatic COVID-19, in 299 residents and 666 staff members (965 total...
...not report other secondary efficacy endpoint results.BLAZE-2 also enrolled 41 residents and 91 staff (132 total...
BioCentury | Jan 15, 2021
Finance

A maturing mid-cap sector could keep funds flowing into biotech

...in 2020, with 148 companies raising a total...
...of 2019 when 100 companies raised a total...
...just via M&A transactions compared with the total...
BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...obtained the fusogen technology by buying Flagship-backed Cobalt Biomedicines Inc. in February 2019 for a total...
BioCentury | Jan 13, 2021
Product Development

On the back of mRNA vaccine validation, Moderna adds three infectious disease programs to pipeline

...vaccine programs to its pipeline, bringing its total...
BioCentury | Jan 13, 2021
Deals

Jan. 12 Quick Takes: $230M series B for Flagship’s ‘gene writer’ Tessera; plus Elucida, Vedanta, AbbVie-Dragonfly, Primmune

...not disclose its investors, raised $28 million in an A round in 2018, bringing its total...
...Inc. topped off its series A round with $4 million from Bioqube Ventures, bringing the total...
BioCentury | Jan 12, 2021
Finance

Diverse syndicate stands behind EQRx’s mission with $500M series B round

...and health systems. It brings the company’s total...
BioCentury | Jan 12, 2021
Deals

Sanofi joins the myeloid checkpoint movement with Biond deal

...be used to advance the rest of the company’s pipeline. The company previously raised a total...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...B for ValoValo Health LLC raised $190 million in a series B round, bringing its total...
Items per page:
1 - 10 of 13818
BioCentury | Jan 27, 2021
Deals

Jan. 26 Quick Takes: Sanofi to manufacture more than 100M doses of Comirnaty; plus Qiming, Nirogy, Takeda-Evozyne and Vir

...RMB 2.9 billion ($441.1 million) to invest in healthcare and technology companies, bringing the firm’s total...
BioCentury | Jan 26, 2021
Politics, Policy & Law

EU transparency scheme raises concerns over potential COVID-19 vaccine export restrictions

...procurement deal is for up to 400 million doses, or about 15% of the EU’s total...
BioCentury | Jan 22, 2021
Product Development

Lilly, AbCellera mAb could enable broad deployment for COVID without taxing infusion centers

...primary endpoint, the incidence of symptomatic COVID-19, in 299 residents and 666 staff members (965 total...
...not report other secondary efficacy endpoint results.BLAZE-2 also enrolled 41 residents and 91 staff (132 total...
BioCentury | Jan 15, 2021
Finance

A maturing mid-cap sector could keep funds flowing into biotech

...in 2020, with 148 companies raising a total...
...of 2019 when 100 companies raised a total...
...just via M&A transactions compared with the total...
BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...obtained the fusogen technology by buying Flagship-backed Cobalt Biomedicines Inc. in February 2019 for a total...
BioCentury | Jan 13, 2021
Product Development

On the back of mRNA vaccine validation, Moderna adds three infectious disease programs to pipeline

...vaccine programs to its pipeline, bringing its total...
BioCentury | Jan 13, 2021
Deals

Jan. 12 Quick Takes: $230M series B for Flagship’s ‘gene writer’ Tessera; plus Elucida, Vedanta, AbbVie-Dragonfly, Primmune

...not disclose its investors, raised $28 million in an A round in 2018, bringing its total...
...Inc. topped off its series A round with $4 million from Bioqube Ventures, bringing the total...
BioCentury | Jan 12, 2021
Finance

Diverse syndicate stands behind EQRx’s mission with $500M series B round

...and health systems. It brings the company’s total...
BioCentury | Jan 12, 2021
Deals

Sanofi joins the myeloid checkpoint movement with Biond deal

...be used to advance the rest of the company’s pipeline. The company previously raised a total...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...B for ValoValo Health LLC raised $190 million in a series B round, bringing its total...
Items per page:
1 - 10 of 13818